News|Articles|June 27, 2024

More Data, More Insights, More Progress

Author(s)Saama

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data. Additionally, this solution would need to aggregate data into one “single source of truth” to inform better decision-making.


Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.